Hoffman R M, Gilliland F D
Albuquerque VA Medical Center, and University of New Mexico School of Medicine, USA.
J Community Health. 1999 Dec;24(6):409-19. doi: 10.1023/a:1018790421714.
Prostate cancer screening has increased dramatically in the past decade, but few studies have looked at population-based testing rates and the factors that influence testing. The objectives of our study were to estimate prostate cancer testing rates for New Mexican men 50 years or older and to identify patient factors associated with testing. We surveyed men using random-digit dialing. Subjects completed a 32-item questionnaire asking about prostate cancer testing; demographics; cancer knowledge, attitudes, and beliefs; health behaviors; and risks for prostate cancer. Associations between patient factors and testing were analyzed with multivariate logistic regression. Two hundred thirty-nine subjects (36% response rate) completed the survey; 95% had heard of prostate cancer and nearly 90% felt that testing was important. Forty-eight percent had been tested, most within the past year. Significant predictors for testing included receiving regular health care (odds ratio = 2.15, 95% CI = 1.07-4.33), being retired (OR = 2.49, 95 CI = 1.18-5.28), and having been diagnosed with prostatic hyperplasia (OR = 3.14, 95% CI = 1.30-7.59). Prostate cancer testing occurred frequently among New Mexican men. The study variables that were the most significant predictors of testing were all markers for access to health care.
在过去十年中,前列腺癌筛查显著增加,但很少有研究关注基于人群的检测率以及影响检测的因素。我们研究的目的是估计新墨西哥州50岁及以上男性的前列腺癌检测率,并确定与检测相关的患者因素。我们使用随机数字拨号对男性进行了调查。受试者完成了一份32项的问卷,询问有关前列腺癌检测、人口统计学、癌症知识、态度和信念、健康行为以及前列腺癌风险等问题。使用多因素逻辑回归分析患者因素与检测之间的关联。239名受试者(应答率为36%)完成了调查;95%的人听说过前列腺癌,近90%的人认为检测很重要。48%的人接受过检测,大多数是在过去一年。检测的显著预测因素包括接受定期医疗保健(比值比=2.15,95%置信区间=1.07-4.33)、退休(比值比=2.49,95%置信区间=1.18-5.28)以及被诊断患有前列腺增生(比值比=3.14,95%置信区间=1.30-7.59)。前列腺癌检测在新墨西哥州男性中经常发生。作为检测最显著预测因素的研究变量均为获得医疗保健的标志。